These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10848680

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Prolonged paralysis after long-term administration of vecuronium in the intensive care unit].
    Tanaka O, Akai H, Takekida S, Tanaka Y, Wake M, Iijima K, Horikawa Y, Ijichi K.
    Masui; 2006 Aug; 55(8):992-4. PubMed ID: 16910480
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA.
    Anesth Analg; 2010 Jan 01; 110(1):64-73. PubMed ID: 19713265
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.
    Rudis MI, Sikora CA, Angus E, Peterson E, Popovich J, Hyzy R, Zarowitz BJ.
    Crit Care Med; 1997 Apr 01; 25(4):575-83. PubMed ID: 9142020
    [Abstract] [Full Text] [Related]

  • 9. Prolonged neuromuscular blockade in a horse following concomitant use of vecuronium and atracurium.
    Gurney M, Mosing M.
    Vet Anaesth Analg; 2012 Jan 01; 39(1):119-20. PubMed ID: 22118190
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
    Bevan JC, Collins L, Fowler C, Kahwaji R, Rosen HD, Smith MF, de Scheepers LD, Stephenson CA, Bevan DR.
    Anesth Analg; 1999 Aug 01; 89(2):333-9. PubMed ID: 10439743
    [Abstract] [Full Text] [Related]

  • 14. Recovery of train-of-four ratio to 0.70 and 0.90 is delayed in type 2 diabetes with vecuronium-induced neuromuscular block.
    Nitahara K, Sugi Y, Shigematsu K, Haraga I, Abe S, Higa K.
    Eur J Anaesthesiol; 2013 Feb 01; 30(2):80-4. PubMed ID: 23172246
    [Abstract] [Full Text] [Related]

  • 15. Early recognition of risk factors for persistent effects of vecuronium.
    Sanders KA, Aucker R.
    South Med J; 1996 Apr 01; 89(4):411-4. PubMed ID: 8614883
    [Abstract] [Full Text] [Related]

  • 16. Neostigmine reversal of vecuronium neuromuscular block and the influence of renal failure.
    Dhonneur G, Rebaine C, Slavov V, Ruggier R, De Chaubry V, Duvaldestin P.
    Anesth Analg; 1996 Jan 01; 82(1):134-8. PubMed ID: 8712389
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients.
    Suzuki T, Masaki G, Ogawa S.
    Br J Anaesth; 2006 Aug 01; 97(2):160-3. PubMed ID: 16782976
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.